Stock Events

Stock Events

Search...

Adaptimmune Therapeutics (ADAP) Q1 2024 Earnings

15MayConfirmed

Q2 2023

Q3 2023

Q4 2023

Q1 2024

-0.24

-0.19

-0.15

-0.1

Details

Expected EPS

-0.1

Actual EPS

-0.18

Surprise EPS

-0.08

Surprise Percent

+80%

Description

Adaptimmune Therapeutics (ADAP) has reported earnings of -0.18 per share for Q1 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.